---
title: Aurigene Pharmaceutical Services Limited vs WuXi AppTec
slug_a: aurigeneservices
slug_b: wuxiapptec
site: cro
review_signal_gate: closed
canonical_path: /compare/aurigeneservices/wuxiapptec
generated_by: BioBM Editorial AI
---

# Aurigene Pharmaceutical Services Limited vs WuXi AppTec

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Aurigene Pharmaceutical Services Limited (aurigeneservices) is listed for both. Integrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries.

Services: 6. Modalities: 3. Indications: 0. Locations: 3. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (6).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

WuXi AppTec (wuxiapptec) is listed for cro. Global CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.

Services: 41. Modalities: 10. Indications: 14. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (41).

Review summary: Review summary withheld until site-level review gate opens.